Canada
· Delayed Price · Currency is CAD Theralase Technologies Statistics
Total Valuation
TSXV:TLT has a market cap or net worth of CAD 47.27 million. The enterprise value is 47.30 million.
| Market Cap | 47.27M |
| Enterprise Value | 47.30M |
Important Dates
The last earnings date was Thursday, March 27, 2025.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:TLT has 248.81 million shares outstanding. The number of shares has increased by 9.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 248.81M |
| Shares Change (YoY) | +9.14% |
| Shares Change (QoQ) | +9.28% |
| Owned by Insiders (%) | 6.88% |
| Owned by Institutions (%) | 0.17% |
| Float | 231.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.14 |
| PB Ratio | 22.77 |
| P/TBV Ratio | 22.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.11 |
| EV / Sales | 45.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.14 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.61 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -177.68 |
Financial Efficiency
Return on equity (ROE) is -214.26% and return on invested capital (ROIC) is -115.19%.
| Return on Equity (ROE) | -214.26% |
| Return on Assets (ROA) | -82.17% |
| Return on Invested Capital (ROIC) | -115.19% |
| Return on Capital Employed (ROCE) | -189.67% |
| Revenue Per Employee | 51,672 |
| Profits Per Employee | -212,806 |
| Employee Count | 20 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 0.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.15% in the last 52 weeks. The beta is 1.20, so TSXV:TLT's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +15.15% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 32.66 |
| Average Volume (20 Days) | 109,823 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:TLT had revenue of CAD 1.03 million and -4.26 million in losses. Loss per share was -0.02.
| Revenue | 1.03M |
| Gross Profit | 554,026 |
| Operating Income | -4.29M |
| Pretax Income | -4.26M |
| Net Income | -4.26M |
| EBITDA | -4.11M |
| EBIT | -4.29M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 268,757 in cash and 293,867 in debt, giving a net cash position of -25,110 or -0.00 per share.
| Cash & Cash Equivalents | 268,757 |
| Total Debt | 293,867 |
| Net Cash | -25,110 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 2.07M |
| Book Value Per Share | 0.01 |
| Working Capital | 597,718 |
Cash Flow
In the last 12 months, operating cash flow was -3.33 million and capital expenditures -19,967, giving a free cash flow of -3.35 million.
| Operating Cash Flow | -3.33M |
| Capital Expenditures | -19,967 |
| Free Cash Flow | -3.35M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 53.61% |
| Operating Margin | -414.96% |
| Pretax Margin | -411.84% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:TLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.14% |
| Shareholder Yield | -9.14% |
| Earnings Yield | -9.00% |
| FCF Yield | -7.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:TLT has an Altman Z-Score of -8.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.58 |
| Piotroski F-Score | n/a |